Literature DB >> 15555529

Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of interferon-gamma.

Natsuo Yamamoto1, Kazuyoshi Kawakami, Yuki Kinjo, Kazuya Miyagi, Takeshi Kinjo, Kaori Uezu, Chikara Nakasone, Masashi Nakamatsu, Atsushi Saito.   

Abstract

Interleukin (IL)-12 is a critical cytokine in the T helper (Th)1 response and host defense against intracellular microorganisms, while its role in host resistance to extracellular bacteria remains elusive. In the present study, we elucidated the role of IL-12 in the early-phase host defense against acute pulmonary infection with Streptococcus pneumoniae, a typical extracellular bacterium, using IL-12p40 gene-disrupted (IL-12p40KO) mice. IL-12p40KO mice were highly susceptible to S. pneumoniae infection, as indicated by the shortened survival time, which was completely restored by the replacement therapy with recombinant (r) IL-12, and increased bacterial counts in the lung. In these mice, recruitment of neutrophils in the lung was significantly attenuated when compared to that in wild-type (WT) mice, which correlated well with the reduced production of macrophage inflammatory protein (MIP-2) and tumor necrosis factor (TNF)-alpha in the infected tissues at the early phase of infection. In vitro synthesis of both cytokines by S. pneumoniae-stimulated lung leukocytes was significantly lower in IL-12p40KO mice than in WT mice, and addition of rIL-12 or interferon (IFN)-gamma restored the reduced production of MIP-2 and TNF-alpha in IL-12p40KO mice. Neutralizing anti-IFN-gamma monoclonal antibody (mAb) significantly decreased the effect of rIL-12. Anti-IFN-gamma mAb shortened the survival time of infected mice and reduced the recruitment of neutrophils and production of MIP-2 and TNF-alpha in the lungs. Our results indicated that IL-12p40 plays a critical role in the early-phase host defense against S. pneumoniae infection by promoting the recruitment of neutrophils to the infected tissues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555529     DOI: 10.1016/j.micinf.2004.08.007

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  31 in total

Review 1.  Pneumococci: immunology of the innate host response.

Authors:  Gavin K Paterson; Carlos J Orihuela
Journal:  Respirology       Date:  2010-07-20       Impact factor: 6.424

2.  Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia.

Authors:  Matthew R Jones; Benjamin T Simms; Michal M Lupa; Mariya S Kogan; Joseph P Mizgerd
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

3.  Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.

Authors:  Jianghong Xu; Wenjia Dai; Zhengmin Wang; Bing Chen; Zhongming Li; Xiaoyong Fan
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

4.  Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection.

Authors:  Keer Sun; Sharon L Salmon; Steven A Lotz; Dennis W Metzger
Journal:  Infect Immun       Date:  2007-01-08       Impact factor: 3.441

5.  Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide.

Authors:  Tamika Burns; Maria Abadi; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice.

Authors:  Sarah E Weber; Haijun Tian; Liise-anne Pirofski
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

7.  Inhibition of T cells provides protection against early invasive pneumococcal disease.

Authors:  Kim LeMessurier; Hans Häcker; Elaine Tuomanen; Vanessa Redecke
Journal:  Infect Immun       Date:  2010-09-20       Impact factor: 3.441

8.  Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.

Authors:  D M Ferreira; M Darrieux; D A Silva; L C C Leite; J M C Ferreira; P L Ho; E N Miyaji; M L S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

9.  Peritoneal challenge modulates expression of pneumococcal surface protein C during bacteremia in mice.

Authors:  Lisa R Quin; Quincy C Moore; Justin A Thornton; Larry S McDaniel
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

10.  Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing.

Authors:  Rachel E Sutherland; Joanna S Olsen; Andrew McKinstry; S Armando Villalta; Paul J Wolters
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.